Scinovex
articleTop 10% cited

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

Journal of Neurology · 1997 · Vol. 244(3) · pp. 153–159
Enrico MillefioriniClaudio GasperiniCarlo PozzilliFrancesco D’AndreaAlessandro BozzaoA CalòM. BerniniD. GambiMassimiliano PrencipeStefano BastianelloMaría TrojanoVincenzo Brescia MorraStefania Morino
Multiple Sclerosis Research StudiesPolyomavirus and related diseasesFungal Plant Pathogen ControlMitoxantroneMedicineMultiple sclerosisExpanded Disability Status ScalePlaceboNeurologyRandomizationClinical trialRandomized controlled trialInternal medicine

MeSH terms

Adjuvants, ImmunologicAdolescentAdultFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMitoxantroneMultiple SclerosisPlacebosRecurrenceRemission InductionTreatment Outcome
Citations
271
FWCI
2.98
field-weighted impact
References
23
Percentile
91%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome · Scinovex